Cleared Traditional

K070708 - OLYMPUS FT4-FREE THYROXINE

K070708 is the FDA 510(k) clearance for OLYMPUS FT4-FREE THYROXINE by Olympus Life & Material Science Europa GmbH (Irish. It is a Class 2 Chemistry device (product code CEC) cleared through the Traditional 510(k) pathway after a 160-day FDA review.

K070708 · Olympus Life & Material Science Europa GmbH (Irish · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2007
Decision
160d
Days
Class 2
Risk

K070708 is an FDA 510(k) clearance for the OLYMPUS FT4-FREE THYROXINE, OLYMPUS T4- TOTAL THYROXINE, MODEL# OSR210102, O.... Classified as Radioimmunoassay, Free Thyroxine (product code CEC), Class II - Special Controls.

Submitted by Olympus Life & Material Science Europa GmbH (Irish (Co. Clare, IE). The FDA issued a Cleared decision on August 21, 2007 after a review of 160 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1695 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Olympus Life & Material Science Europa GmbH (Irish devices

Submission Details

510(k) Number K070708 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 14, 2007
Decision Date August 21, 2007
Days to Decision 160 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
72d slower than avg
Panel avg: 88d · This submission: 160d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CEC Radioimmunoassay, Free Thyroxine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1695
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CEC Radioimmunoassay, Free Thyroxine

All 64
Devices cleared under the same product code (CEC) and FDA review panel - the closest regulatory comparables to K070708.
IMMULITE 2000 FREE T4
K083373 · Siemens Healthcare Diagnostics, Inc. · Feb 2009
ACS 180 AND ADVIA CENTAUR FT4 IMMUNOASSAYS
K080167 · Siemens Healthcare Diagnostics · Aug 2008
DIMENSION EXL WITH LM CLINICAL CHEMISTRY SYSTEM, DIMENSION FT4L FLEX REAGENT CARTRIDGE, AND LOCI THYROID CALIBRATOR, MOD
K073604 · Dade Behring, Inc. · Mar 2008
DIMENSION VISTA FREE THYROXINE FLEX REAGENT CARTRIDGE AND LOCI 1 CALIBRATOR
K053531 · Dade Behring, Inc. · Mar 2006
ABBOTT ARCHITECT FREE T4
K983417 · Abbott Laboratories · Nov 1998
ACCESS FREE T4 REAGENTS ON THE ACCESS IMMUNOASSAY ANALYZER
K982250 · Beckman Instruments, Inc. · Jul 1998